Evidence map›Paper›PMID 33839903›Full record

ArticlePsychopharmacology2021

Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice.

Miquel Martin, Miriam Gutiérrez-Martos, Roberto Cabrera, Klaus Langohr, Rafael Maldonado, Magi Farre, Rafael de la Torre

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Miquel MartinIntegrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute (IMIM), Parc de Recerca Biomedica de Barcelona (PRBB), C/Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7771-611X
Miriam Gutiérrez-MartosLaboratory of Neuropharmacology, Parc de Recerca Biomedica de Barcelona (PRBB), Universitat Pompeu Fabra, C/Dr. Aiguader 88, 08003, Barcelona, Spain.
Roberto CabreraLaboratory of Neuropharmacology, Parc de Recerca Biomedica de Barcelona (PRBB), Universitat Pompeu Fabra, C/Dr. Aiguader 88, 08003, Barcelona, Spain.
Klaus LangohrIntegrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute (IMIM), Parc de Recerca Biomedica de Barcelona (PRBB), C/Dr. Aiguader 88, 08003, Barcelona, Spain.
Rafael MaldonadoLaboratory of Neuropharmacology, Parc de Recerca Biomedica de Barcelona (PRBB), Universitat Pompeu Fabra, C/Dr. Aiguader 88, 08003, Barcelona, Spain.
Magi FarreIntegrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute (IMIM), Parc de Recerca Biomedica de Barcelona (PRBB), C/Dr. Aiguader 88, 08003, Barcelona, Spain.
Rafael de la TorreIntegrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute (IMIM), Parc de Recerca Biomedica de Barcelona (PRBB), C/Dr. Aiguader 88, 08003, Barcelona, Spain. RTorre@imim.es.
Universitat Pompeu Fabra · ESBarcelona Biomedical Research Park · ESUniversitat Autònoma de Barcelona · ES

Funding

Departament de Salut, Generalitat de Catalunya 2015-BAPPDepartament de Salut, Generalitat de Catalunya 2015-NeuroPharDepartament de Salut, Generalitat de Catalunya 2017-SGR-138Departament de Salut, Generalitat de Catalunya 2017 SGR 669Departament de Salut, Generalitat de Catalunya #2017-SRG-316Departament de Salut, Generalitat de Catalunya TECCIT2014Instituto de Salud Carlos III CIBEROBNInstituto de Salud Carlos III RD16/0017/0020Instituto de Salud Carlos III RD16/0017/003Ministerio de Ciencia Tecnología y Telecomunicaciones EC10-166
6 · The paper itself

Abstract

rationaleCocaine addiction is a chronic relapsing disorder that lacks of an effective treatment. Isoflavones are a family of compounds present in different plants and vegetables like soybeans that share a common chemical structure. Previous studies have described that synthetic derivatives from the natural isoflavone daidzin can modulate cocaine addiction, by a mechanism suggested to involve aldehyde-dehydrogenase (ALDH) activities.

objectivesBased on these previous studies, we investigated the effects of three natural isoflavones, daidzin, daidzein, and genistein, on the modulation of the cocaine reinforcing effects and on cue-induced reinstatement in an operant mouse model of cocaine self-administration.

resultsChronic treatment with daidzein or genistein decreased operant responding to obtain cocaine intravenous infusions. On the other hand, daidzein and daidzin, but not genistein, were effective in decreasing cue-induced cocaine reinstatement. Complementary studies revealed that daidzein effects on cocaine reinforcement were mediated through a mechanism that involved dopamine type-2/3 receptors (DA-D2/3) activities.

conclusionsOur results suggest that these natural compounds alone or in combination can be a potential therapeutic approach for cocaine addiction. Further clinical studies are required in order to ascertain their potential therapeutic use.

Indexed as

CuesReinforcement, PsychologyAnimalsCocaineCocaine-Related DisordersConditioning, OperantDopamine Uptake InhibitorsDose-Response Relationship, DrugExtinction, PsychologicalIsoflavonesLocomotionMaleMicePhytoestrogensSelf AdministrationCocainedaidzeinDopamine Uptake InhibitorsIsoflavonesPhytoestrogenscocainedaidzeindaidzindopamine receptorsgenisteinisoflavonesreinforcingreinstatementself-administration

Identifiers

PMID33839903
PMCPMC8233246
OpenAlexW3152964977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.